| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/23/2005 | CN1599739A Sulfonamido substituted imidazopyridines |
| 03/23/2005 | CN1599738A Urea substituted imidazopyridines |
| 03/23/2005 | CN1599737A Ring fused pyrazole derivatives |
| 03/23/2005 | CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists |
| 03/23/2005 | CN1599730A Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 03/23/2005 | CN1599726A Pyrimidine compounds |
| 03/23/2005 | CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/23/2005 | CN1599721A CCR-3 receptor antagonists VII |
| 03/23/2005 | CN1599626A Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 03/23/2005 | CN1599620A Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 03/23/2005 | CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/23/2005 | CN1599613A Combinations for the treatment of immunoinflammatory disorders |
| 03/23/2005 | CN1599611A Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 03/23/2005 | CN1599600A Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 03/23/2005 | CN1599594A Solid oral compositions |
| 03/23/2005 | CN1597957A A group nucleodite sequence of anti-hepatitis virus C infection and preventing and curing hepatitis virus C and its segment and application |
| 03/23/2005 | CN1597677A Compounds and methods for modulation of estrogen receptors |
| 03/23/2005 | CN1596984A Malt injection and its processing technology |
| 03/23/2005 | CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 03/23/2005 | CN1596978A Combined vaccine for hepatitis A, B virus and its preparation method |
| 03/23/2005 | CN1596971A Kidney supplementing life prolonging preparation and its making method |
| 03/23/2005 | CN1596970A Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method |
| 03/23/2005 | CN1596968A Kidney supplementing life prolonging effervescent tablet and its preparation method |
| 03/23/2005 | CN1596967A Kidney supplementing life prolonging granules and its preparation method |
| 03/23/2005 | CN1596951A Phellodendron bark disperse tablet and its preparation method |
| 03/23/2005 | CN1596935A Medicine for treating baby and child diarrhea and its preparation method |
| 03/23/2005 | CN1596924A Chinese and western modicinal compound formula for treating oral cavity throat disease |
| 03/23/2005 | CN1596920A Medicinal composition for treating cardiopathy and its preparation method and use |
| 03/23/2005 | CN1596919A Application for treating hepatism |
| 03/23/2005 | CN1596918A Preparation method of mint oil softcapsule for treating chronic cholecystitis |
| 03/23/2005 | CN1596913A Liver-nourishing kidney protecting fat lowering tea |
| 03/23/2005 | CN1596898A Biammonium glycyrrhizate powder-injection and its preparation method |
| 03/23/2005 | CN1596893A Cimetidine freeze-dried powder-injection and its preparation method |
| 03/23/2005 | CN1596889A Vitamin E emulsion and its freeze-dried emulsion compound and preparation method |
| 03/23/2005 | CN1596883A Compound dichloroacetic acid diisopropylamin powder-injection and its preparation method |
| 03/23/2005 | CN1596882A Vitamin K1 emulsion and its freeze-dried emulsion and preparation method |
| 03/23/2005 | CN1194006C Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 03/23/2005 | CN1193781C Medicine for treating aphtha |
| 03/23/2005 | CN1193766C Gardenia total glydcoside composite for treating hepatitis and its preparation method |
| 03/23/2005 | CN1193760C Licorzinc solution composition, preparation process tereof and licorxinc preparation |
| 03/23/2005 | CN1193746C Substituted nitrobenzene derimative for medicine and other use |
| 03/23/2005 | CN1193743C Multilayer pharmaceutical product for release in the colon |
| 03/23/2005 | CN1193739C Chinese herbal medicine lotion for skin care of infant |
| 03/23/2005 | CN1193735C Oral cleaning liquid |
| 03/23/2005 | CN1193734C Oral liquor capable of preventing dental caries and reliveing inflammation |
| 03/23/2005 | CN1193675C Kidney-warming yang-strengthening tea |
| 03/22/2005 | US6870070 Hydrogenation, resoulution, alkylation, bromination, andcarboxamidation |
| 03/22/2005 | US6869975 Linked biaryl compounds |
| 03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 03/22/2005 | US6869964 Inhibiting NS3 (non-structural proteins) proteases; tripeptides |
| 03/22/2005 | US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/22/2005 | US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine) |
| 03/22/2005 | US6869956 Such as 4-(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline; kits; treating arthritis, psoriasis, inflammatory bowel disease, autoimmune diseases and neurodegenerative diseases among others |
| 03/22/2005 | US6869955 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
| 03/22/2005 | US6869954 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869949 Such as 8-hydroxy-2,3-dimiethyl-9-(3-thienyl)-7,8,9,10-tetrahydroimidazo(1,2 -h)(1,7)napththyridin-7-one |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/22/2005 | CA2330092C Benzimidazole compounds as orl1-receptor agonists |
| 03/22/2005 | CA2257772C Bicyclic¬3.1.0|hexanes and related compounds |
| 03/22/2005 | CA2178219C Substituted morpholine derivatives and their use as therapeutic agents |
| 03/17/2005 | WO2005024004A1 Method of differentiating mesenchymal stem cell into liver cell and artificial human liver cell |
| 03/17/2005 | WO2005023808A2 Process for the preparation of renzapride and intermediates thereof |
| 03/17/2005 | WO2005023797A1 New salts of omeprazole and esomeprazole ii |
| 03/17/2005 | WO2005023796A1 New salts of omeprazole and esomeprazole i |
| 03/17/2005 | WO2005023782A1 Substituted fused pyrimidine-4(3h)-one compound |
| 03/17/2005 | WO2005023771A1 Chemokine receptor antagonist and medical use thereof |
| 03/17/2005 | WO2005023764A1 Salt of atorvastatin with ranitidine |
| 03/17/2005 | WO2005023741A2 Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives |
| 03/17/2005 | WO2005023289A1 Medicinal composition for treating chronic hepatitis c |
| 03/17/2005 | WO2005023280A1 Oral treatment for anorectal conditions |
| 03/17/2005 | WO2005023275A1 Pharmaceutical active ingredient against hepatitis |
| 03/17/2005 | WO2005023244A1 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof |
| 03/17/2005 | WO2005023210A1 Recalcification-promoting agent, oral composition, food and drink |
| 03/17/2005 | WO2005014032A3 Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite |
| 03/17/2005 | WO2005002563A3 Method for treating alcoholic hepatitis |
| 03/17/2005 | WO2005000820A3 4-cyanopyrazole-3-carboxamide derivatives preparation and application thereof as cb1 cannabinoid antagonists |
| 03/17/2005 | WO2005000817A3 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 03/17/2005 | WO2004082669A3 Antiflatulents in combibation with histamine h1-receptor antagonist for treating gastrointestinal disoders |
| 03/17/2005 | WO2004069165A3 Methods and compositions for the treatment of gastrointestinal disorders |
| 03/17/2005 | WO2004056862A3 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 03/17/2005 | WO2004056809A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/17/2005 | WO2004056808A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/17/2005 | WO2004045612A8 Use of a proton pump inhibitor for preventing postoperative nausea and vomiting |
| 03/17/2005 | WO2003061564A8 Gene expression profiles in liver disease |
| 03/17/2005 | WO2003045918A8 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 03/17/2005 | WO2003043619A8 New use for the treatment of gastroesophageal reflux disease |
| 03/17/2005 | WO2003037887A8 Therapeutic isoquinoline compounds |
| 03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
| 03/17/2005 | US20050059735 Cyclic amino acid derivatives useful as pharmaceutical agents |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059721 Nonsedating alpha-2 agonists |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059683 A1 adenosine receptor antagonists |
| 03/17/2005 | US20050059666 CCR5 antagonists useful for treating AIDS |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059625 Immunostimulatory nucleic acid molecules |
| 03/17/2005 | US20050059618 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |